english.jpnn.com, CHINA - The top Covid-19 vaccine manufacturer in China, Sinovac Biotech, looks forward to further collaboration with Indonesia in vaccine development as the world is battling against the Omicron variant.
"We have a long-term plan and we are working closely with stakeholders in Indonesia," said Meng Weining, president of Sinovac Life Sciences, at an online press briefing on Tuesday.
ALSO SEE: Indonesia's Economic Growth Overtakes China: BPS
Regarding the Red-White vaccine developed by Indonesia, he admitted that he did not know much about the program.
His party seeks to continue to establish further communication with Indonesia to monitor the current Covid-19 situation and intend this collaboration to focus on public health.
ALSO SEE: China Vows to Retaliate for US Action to Revoke Unicom's License
Meng stated that CoronaVac, a vaccine developed by Sinovac, was effective in fighting the Omicron variant.
Data from their research in several countries showed that their booster vaccine was effective against Omicron, he added.
ALSO SEE: China Reports First Iranian Oil Imports Amid US Sanctions
Even so, his party together with experts from China are conducting further research to determine the efficacy of the CoronaVac vaccine.
After they received a distribution permit from the Chinese government in December, they would distribute the vaccine against Omicron to Indonesia, he said.
According to him, Sinovac is also developing a multivariate vaccine while still using the inactive method.
The CoronaVac vaccine is claimed to be safe for use by people of all ages and at high risk.
Sinovac's production capacity at its three factories in Beijing City and Liaoning Province reaches 13 million doses of CoronaVac per day, so Meng is optimistic that they can meet the needs of Covid-19 vaccines from various countries, including Indonesia.
Since January 2021, Sinovac has distributed more than 280 million doses of vaccine to Indonesia. (ant/dil/mcr20/jpnn)
This news has been broadcast on JPNN.com with the title: Sinovac Makin Intens Dekati Indonesia, Sasar Kerja Sama Jangka Panjang